Tag: PNETs
10 Highlights of the Year 2014 for the Carcinoid and Neuroendocrine Tumor Community
As the Carcinoid Cancer Foundation looks back on the year 2014, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past…
READ MORE
New OncLive TV Series Focuses on Pancreatic Neuroendocrine Tumors
Pancreatic neuroendocrine tumors, also known as pNETs, form in the hormone-making cells (islet cells) of the pancreas. In this new OncLive TV series, moderator Matthew Kulke, MD, Director of the Program in Neuroendocrine and Carcinoid Tumors at Dana-Farber/Brigham…
READ MORE
New OncLive TV Series Focuses on Neuroendocrine Tumors
Carcinoid and neuroendocrine tumors (NETs), including pancreatic neuroendocrine tumors and even more uncommon NETs such as goblet cell carcinoid and mixed adenocarcinomas, are discussed by a panel of medical experts in this new video series from …
READ MORE
New Online Pancreatic Neuroendocrine Tumor (pNET) Support Community
There’s a wonderful new resource for pancreatic neuroendocrine tumor (pNET) patients and their loved ones at Inspire, the creator of online health and wellness communities for patients and caregivers, in partnership with national patient advocacy…
READ MORE
Worldwide NET Cancer Awareness Day Alliance Launches Zebra Cartoon Sequel
Global recognition of the need for NET (neuroendocrine tumor) cancer awareness will be marked by the third annual worldwide NET Cancer Day on November 10, 2012. In anticipation of the day, the Worldwide NET Cancer Awareness Day Alliance has launched…
READ MORE
Breaking News: Pancreatic NET Cancer Patient Steve Jobs Steps Down as CEO of Apple
On August 24, 2011, Steve Jobs, CEO of Apple, announced that he was stepping down from his position. In his letter to the Apple Board of Directors and the Apple Community, Mr. Jobs wrote, “I have always said if there ever came a day when I could no longer meet…
READ MORE
Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients
The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread (metastasized) to …
READ MORE
Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients
The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread (metastasized) to …
READ MORE
Breaking News: FDA Approves Treatment for pNET Patients
For the first time in nearly three decades, there is a new treatment for pancreatic neuroendocrine tumor patients! The Food and Drug Administration (FDA) today announced its approval of Afinitor© for pNET patients. This is a milestone for the carcinoid/NET…
READ MORE
Carcinoid Cancer Foundation to Speak on Behalf of NET Cancer Patients at April 12, 2011 FDA Oncologic Drugs Advisory Committee Meeting
Grace Goldstein, Chief Operating Officer of the Carcinoid Cancer Foundation, will speak at the Open Public Hearing segment during the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee Meeting on April 12, 2011 in Silver …
READ MORE
